Navigation Links
Meeting to examine FDA requirements for manufacturing PET radiopharmaceuticals
Date:3/26/2009

Reston, VASNM and the International Partnership for Critical Markers of Disease (CMOD) are co-hosting an in-depth meeting on Friday, May 1, 2009, examining FDA requirements for manufacturing positron emission tomography (PET) radiopharmaceuticals. The meeting, which takes place at the Natcher Auditorium, National Institutes of Health, Bethesda, Md., is scheduled to begin at 6:10 p.m. and conclude at 9:45 p.m.

"We are pleased to collaborate with the International Partnership for Critical Markers of Disease on this important meeting," said Michael Graham, M.D., Ph.D., SNM president-elect and director of nuclear medicine at the University of Iowa Carver College of Medicine. "New developments in molecular imaging technologies are dramatically improving the ways in which cardiovascular disease, neurological disorders and cancer are diagnosed and treated. It is essential that we work together as a scientific community to facilitate personalized medicine through the development of advanced imaging techniques and new radiopharmaceuticals that will enable physicians to determine early on the precise location of disease, and evaluate and monitor the effectiveness of therapy."

"SNM and CMOD share a common interest in accelerating scientific research to bring the best in health care to patients today," said Thrse Heinonen, DVM, executive director of the International Partnership for Critical Markers of Disease. "With an active interest in the evaluation of potential cardiovascular biomarkers and their appropriate application in clinical trials, a partnership with SNM is a natural fit."

Don Black, head of research and development at GE Healthcare's Medical Diagnostics, Dwaine Rieves, director of medical imaging at the U.S. Food and Drug Administration, and Michael Graham from SNM will kick off the special May 1 evening session. Dennis Swanson, University of Pittsburgh, and Sally Schwarz, Washington University, will survey the regulation history of PET and review current regulations for PET compounding. Joseph Hung, Mayo Clinic, along with other distinguished speakers, will address the critical necessity of developing new tracers and radiopharmaceuticals in compliance with FDA's current good manufacturing practice (CGMP) and chemistry, manufacturing and control (CMC) regulations. Experts will then address the need for harmonization and standardization across multiple imaging sites and discuss the concept of a centralized IND and SNM's new Clinical Trials Network. The meeting will conclude with an interactive question and answer session and panel discussion.

This meeting will take place immediately following SNM's Multimodality Cardiovascular Molecular Imaging Symposium (CVMI), Apr. 30May 1, also at the Natcher Auditorium of the National Institutes of Health. CVMI Symposium attendees may register for this session at no additional charge. For more information about this symposium and to register, please visit www.snm.org/cvmi2009.

SNM and CMOD plan to host other collaborative symposia and forums dedicated to accelerating biomarker and radiopharmaceutical development for patient care, including the 7th annual CMOD Biomarkers and Surrogate Endpoints Symposium, Oct. 19󈞁, 2009, Bethesda, Md. This symposiumwith the theme, "Streamlining to Promote Innovation and Efficiency"will also be held in collaboration with representatives from the FDA, National Institutes of Health, Centers for Disease Control and Prevention, U.S. Agency for Healthcare Research and Quality, Canadian Institutes for Health Research, Radiological Society of North America, and other public and private research organizations. To register for the fall symposium, please visit www.cmod.org.

Registration is free for members of the press or freelancers with a letter of assignment. Press should contact Amy Shaw at ashaw@snm.org or Kathryn Wiley at kwiley@snm.org for more information, or telephone (703) 652-6773.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
2. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
3. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
4. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
5. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
6. SCAI and ACC announce new interventional cardiology meeting
7. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
8. International Society of Hair Restoration Surgery Hosts 15th Annual Scientific Meeting in Las Vegas, September 26-30, 2007
9. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
10. Meeting Expectations Named to First Annual CMI 25 List by Corporate Meetings & Incentives Magazine
11. UNCOVERING THE TRUTH - A Town Hall Meeting on Mental Health Parity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Petersburg Florida (PRWEB) , ... March 28, 2017 , ... ... Marine Corp to raise money to for the Toys for Tots Literacy Campaign at ... federal budget in excess of $70 billion, the U.S. ranks at number 14 internationally ...
(Date:3/28/2017)... ... March 28, 2017 , ... AutismOne announced ... American Association of Integrative Medicine and available for application on Saturday, May 27, ... 2017 Conference in Colorado Springs. , Ed Arranga, president of AutismOne, stated: "Many ...
(Date:3/28/2017)... ... March 28, 2017 , ... The ... in Atlantic City March 13-16, was a busy spot this year. Liz Solovay ... discussed strategies for preventing outbreaks among camp communities during the upcoming 2017 camping ...
(Date:3/28/2017)... ... ... a common and unwelcomed occurrence in people of all ages, genders and ethnicities. Dermatologist Dr. ... of dealing with excess skin oil. “Oily skin is a challenge to many of my ... the oily shine while keeping the skin fresh and clean,” says Dr. Au. , What ...
(Date:3/28/2017)... ... ... thrilling adventure that reveals the mystery of Kevin’s purpose. “A Prophets Bones” is the creation ... asked of him that he had neglected to do, but this was from God and ... some who would have felt themselves to be special and better than others due to ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... BOSTON , March 28, 2017 /PRNewswire/ ... today announced a partnership with premium news ... allows pharmaceutical companies to extract key insights from ... text mining technology. The Linguamatics I2E ... top 20 global pharmaceutical companies. The Linguamatics-Dow Jones ...
(Date:3/28/2017)...  Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: ... directors: Christopher Gabrieli , ... as chairman of the board of Akcea Therapeutics. ... Forest Laboratories. Sandford D. Smith , ... "We are excited to announce this expansion to our ...
(Date:3/28/2017)... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... Office (JPO) for the composition of matter of ... the treatment or prevention of fibrotic disorders, including ... retinopathy (Japanese Patent #: 6060071).  This patent includes ...
Breaking Medicine Technology: